Rachel Braun Scherl
As President, Rachel is building on her track record of success, developing teams committed to creating a company that provides essential sexual satisfaction and health products and services to women.
A seasoned executive, Rachel has focused on driving growth through innovation, building Fortune 500 brands, revitalizing stagnant brands, and creating opportunities for 20 years. Upon graduating from Stanford University Graduate School of Business in 1992, Rachel joined Johnson & Johnson's McNeil Consumer Healthcare division (now McNeil Consumer and Specialty Pharmaceuticals), where she worked with a core team to manage the company's flagship Tylenol® brand.
Rachel continued her relationship with Johnson & Johnson as a principal with the consulting firm Marketing Corporation of America. She took a leadership role in identifying and building growth opportunities for global OTC, pharmaceutical and consumer products leaders within the Johnson & Johnson family of companies, as well as for other market leaders such as American Express and Disney.
In 1998, Rachel joined forces with colleague Mary Wallace Jaensch to co-found The Jannick Group, LLC/SPARK Solutions for Growth. Over the course of a decade, the firm provided guidance and expertise to Fortune 100 firms, including multiple divisions and operating companies of Johnson & Johnson, Wyeth, Deloitte & Touche and GlaxoSmithKline.
In the latest chapter of its two principals' 11-year partnership, The Jannick Group teamed with Quaker BioVentures in 2008 to create Semprae Laboratories, Inc. and focus on developing and marketing women's sexual health products. As President, Rachel is building on her track record of success, developing teams committed to creating a company that provides essential sexual satisfaction and health products and services to women.